Induction of apoptosis by beta-diketones in human tumor cells

Kensuke Nakano1, Tohru Nakayachi, Eiji Yasumoto

  • 1Department of Dental Pharmacology, Meikai University School of Dentistry, Sakado, Saitama, Japan.

Anticancer Research
|May 27, 2004
PubMed

Insights

Researchers screened beta-diketones for cancer cell toxicity. 3-formylchromone (BD17) showed potent, tumor-specific cytotoxicity against oral cancer cells, inducing apoptosis and warranting further study as a potential cancer therapeutic.

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Cancer Biology

Background:

  • Beta-diketones are a class of organic compounds with diverse biological activities.
  • Oral cancer remains a significant global health challenge, necessitating novel therapeutic strategies.
  • Curcumin and dibenzoylmethane are known for their anti-cancer properties.

Purpose of the Study:

  • To evaluate the cytotoxic effects of various beta-diketones against oral human normal and tumor cell lines.
  • To identify novel beta-diketone compounds with potent and selective anti-cancer activity.
  • To investigate the mechanisms of action for promising compounds, including apoptosis induction.

Main Methods:

  • Cytotoxicity assays were performed on human oral squamous cell carcinoma (HSC-2) and normal gingival fibroblast (HGF) cells.
  • Twenty-two beta-diketone compounds (BD1-22) were screened.
  • Apoptosis induction was assessed by DNA fragmentation, caspase activation (caspase 3, 8, 9), and mitochondrial membrane potential changes.

Main Results:

  • 3-formylchromone (BD17) exhibited significant cytotoxicity against HSC-2 cells (CC50=7.8 microg/mL), outperforming curcumin (CC50=23.6 microg/mL).
  • BD17 demonstrated tumor-specific cytotoxicity, with minimal impact on normal HGF cells.
  • BD17 induced apoptosis in HSC-2 and HL-60 cells via DNA fragmentation, caspase activation, and mitochondrial dysfunction.
  • Enantiomers (-)-3- (BD13) and (+)-3-(Trifluoroacetyl)camphor (BD12) showed cytotoxicity comparable to curcumin.

Conclusions:

  • 3-formylchromone (BD17) possesses potent and tumor-specific cytotoxic activity against oral cancer cells.
  • BD17 effectively induces apoptosis, suggesting its potential as a novel cancer chemotherapeutic agent.
  • Further preclinical studies are warranted to explore the therapeutic efficacy of BD17.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...